Phase 1b/II Trial of Carfilzomib with Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Subjects (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/1611/30/18

Funding

  • Amgen, Inc ( Award # ): $11,200.00